[The pharmacokinetics of nalidixic acid administered parenterally. Towards rational use in severe infections (author's transl)]. 1979

J P Tillement, and G Houin, and F Lhoste, and P d'Athis, and C Lartigue, and M Rapin

Nalidixic acid is effective toward Gram negative infections but its short half-life and potential neurological toxicity explain that its parenteral use is hazardous. Interindividual variations of its pharmacokinetic parameters explain also the absolute necessity of a careful drug monitoring adapted to each patient. The study of plasma kinetics of a single dose of nalidixic acid injected by intravenous route, shows these metabolic variations. With this results, the predicted plasma drug concentrations show that classical dosage regimens are adapted only to a little number of patients. Advantages and inadequacies of a single daily intravenous infusion of nalidixic acid are next analysed.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D009268 Nalidixic Acid A synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA GYRASE. Nalidixin,Nalidixate Sodium,Nalidixate Sodium Anhydrous,Nevigramon,Sodium Nalidixic Acid, Anhydrous,Sodium Nalidixic Acid, Monohydrate,Acid, Nalidixic,Anhydrous, Nalidixate Sodium,Sodium Anhydrous, Nalidixate,Sodium, Nalidixate
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases

Related Publications

J P Tillement, and G Houin, and F Lhoste, and P d'Athis, and C Lartigue, and M Rapin
December 1980, The Journal of infection,
J P Tillement, and G Houin, and F Lhoste, and P d'Athis, and C Lartigue, and M Rapin
January 1978, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
J P Tillement, and G Houin, and F Lhoste, and P d'Athis, and C Lartigue, and M Rapin
January 1980, Therapie,
J P Tillement, and G Houin, and F Lhoste, and P d'Athis, and C Lartigue, and M Rapin
September 1976, Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille,
J P Tillement, and G Houin, and F Lhoste, and P d'Athis, and C Lartigue, and M Rapin
January 1981, Zeitschrift fur Hautkrankheiten,
J P Tillement, and G Houin, and F Lhoste, and P d'Athis, and C Lartigue, and M Rapin
December 1991, Journal of veterinary pharmacology and therapeutics,
J P Tillement, and G Houin, and F Lhoste, and P d'Athis, and C Lartigue, and M Rapin
September 1978, Tijdschrift voor diergeneeskunde,
J P Tillement, and G Houin, and F Lhoste, and P d'Athis, and C Lartigue, and M Rapin
January 1965, Urologia internationalis,
J P Tillement, and G Houin, and F Lhoste, and P d'Athis, and C Lartigue, and M Rapin
June 1979, Deutsche medizinische Wochenschrift (1946),
J P Tillement, and G Houin, and F Lhoste, and P d'Athis, and C Lartigue, and M Rapin
August 1995, Journal of veterinary pharmacology and therapeutics,
Copied contents to your clipboard!